Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.
about
Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis.Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis.The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery.Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer.Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancerResponse to afatinib in treatment-naïve patients with advanced mutant epidermal growth factor receptor lung adenocarcinoma with brain metastases.Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion.
P2860
Q35962441-C5F7E70F-0C5E-43AB-B1C7-0DE50AE7290BQ36187196-0E3B6799-4396-4248-9E2A-72ED1360095BQ36243003-A67D964D-97D2-4BAA-9228-5D051A2AC6ACQ37702787-81FB6518-5334-4A0F-9F24-D6123BA4527FQ38763104-5F14384A-BEC3-49D1-970B-7458EB270357Q39041541-3B842204-53D7-4F2C-9AC7-537D1EB7079FQ41301755-1EFA4D15-EE68-4135-BAE0-F0FB268F1AC0Q47367544-A2D870E1-E3F5-49D6-ABB3-42824D07181EQ47768004-A2DBCC09-0E18-4094-AEB2-4128D809CD11Q54962187-9EFD5B71-ACDE-4FDC-AE33-1E6F129D4818
P2860
Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation on efficacy and saf ...... atients with brain metastases.
@ast
Evaluation on efficacy and saf ...... atients with brain metastases.
@en
type
label
Evaluation on efficacy and saf ...... atients with brain metastases.
@ast
Evaluation on efficacy and saf ...... atients with brain metastases.
@en
prefLabel
Evaluation on efficacy and saf ...... atients with brain metastases.
@ast
Evaluation on efficacy and saf ...... atients with brain metastases.
@en
P2093
P2860
P356
P1433
P1476
Evaluation on efficacy and saf ...... atients with brain metastases.
@en
P2093
Shuimei Luo
Xianhe Xie
Xiuping Chen
P2860
P304
16725-16734
P356
10.18632/ONCOTARGET.4264
P407
P577
2015-06-01T00:00:00Z